News

September 21st, 2021

inSoma Awarded NIH Grant to Develop 3D Cell Culture Platform

inSoma Bio is excited to announced we have been awarded additional support funding from the National Institute of Health (NIH) for the development of a 3D cell culture platform for organoids and stem cells. This new technology will be validated by the University of Chapel Hill for its unique ability to grow and release sensitive cell types from culture without the need for harmful enzymes.

Read more
July 21st, 2021

inSoma Awarded NSF Grant to Advance Tissue Reconstruction

inSoma Bio has been awarded a highly competitive grant through the National Science Foundation (NSF) to further developed our Fractomer product for use in soft tissue reconstruction. This support will allow inSoma to further develop our Fractomer scaffold into a full suite of products suitable for use in several unique plastic surgery markets.

 

Read more
November 15th, 2020

inSoma Bio Finalizes Seed Round

After an eventful few months, inSoma is pleased to announce the close of our seed round. We are extremely grateful to and excited to work with each of our investors in the coming years!